[1] 刘海龙, 杨蕾, 朱银川, 等. 急性心肌梗死合并多支血管病变患者早期完全血运重建的临床疗效及预后分析[J]. 山东医药, 2017, 57(17): 25. doi: 10.3969/j.issn.1002-266X.2017.17.008
[2] 沙莎, 武文君, 冯崴. 不同治疗途径的急性心肌梗死病人淋巴细胞亚群表达变化分析[J]. 蚌埠医学院学报, 2020, 45(7): 868.
[3] LEE MJ, PARK SO, KWON SW, et al. Relation between neutrophil-to-lymphocyte ratio and index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Am J Cardiol, 2016, 118(9): 1323. doi: 10.1016/j.amjcard.2016.07.072
[4] 徐林, 陶波. 中性粒细胞淋巴细胞比值与急性心肌梗死的相关性研究[J]. 中国心血管病研究, 2017, 15(8): 692. doi: 10.3969/j.issn.1672-5301.2017.08.006
[5] CHEN C, CONG BL, WANG M, et al. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients[J]. Integr Med Res, 2018, 7(2): 192. doi: 10.1016/j.imr.2018.02.006
[6] 徐娜, 唐晓芳, 许晶晶, 等. 中性粒细胞与淋巴细胞比值对急性心肌梗死合并多支血管病变患者远期预后的预测价值[J]. 中华心血管病杂志, 2019, 47(1): 42. doi: 10.3760/cma.j.issn.0253-3758.2019.01.005
[7] CAPODANNO D, MORICE MC, ANGIOLILLO DJ, et al. Trial design principles for patients at high bleeding risk undergoing PCI: JACC scientific expert panel[J]. J Am Coll Cardiol, 2020, 76(12): 1468. doi: 10.1016/j.jacc.2020.06.085
[8] GAUDINO M, HAMEED I, FARKOUH ME, et al. Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery: A Meta-analysis[J]. JAMA Intern Med, 2020, 180(12): 1638. doi: 10.1001/jamainternmed.2020.4748
[9] 魏小红, 刘文娴, 陈立颖, 等. 急性心肌梗死合并心源性休克患者急诊冠脉介入术后院内死亡危险因素分析[J]. 中华急诊医学杂志, 2019, 28(5): 619. doi: 10.3760/cma.j.issn.1671-0282.2019.05.017
[10] WU Z, HUANG Z, JI W, et al. Peripheral inflammatory biomarkers for myocardial infarction risk: A prospective community-based study[J]. Clin Chem, 2017, 63(3): 663. doi: 10.1373/clinchem.2016.260828
[11] HORNE BD, ANDERSON JL, JOHN JM, et al. Which white blood cell subtypes predict increased cardiovascular risk?[J]. J Am Coil Cardiol, 2005, 45(10): 1638. doi: 10.1016/j.jacc.2005.02.054
[12] AZAB B, ZAHER M, WEISERBS KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short and long term mortality after non-sT-elevation myocardial infarction[J]. Am J CardioL, 2010, 106(4): 470. doi: 10.1016/j.amjcard.2010.03.062
[13] 高立建, 陈纪林. 急性sT段抬高型心肌梗死合并多支血管病变行完全血运重建的最新进展[J]. 中国循环杂志, 2017, 32(7): 625. doi: 10.3969/j.issn.1000-3614.2017.07.001
[14] BUTT K, D'SOUZA J, YUAN C, et al. Correlation of the neutrophil-to-lymphocyte ratio(NLR) and platelet-to-lymphocyte ratio(PLR) with contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary interventions[J]. Cureus, 2020, 12(12): e11879.
[15] LUCCI C, COSENTINO N, GENOVESE S, et al. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus[J]. Cardiovasc Diabetol, 2020, 19(1): 183. doi: 10.1186/s12933-020-01157-7